# A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

> **NCT03270956** · PHASE2 · COMPLETED · sponsor: **Prokidney** · enrollment: 10 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Chronic Kidney Disease

## Interventions

- **BIOLOGICAL:** Renal Autologous Cell Therapy (REACT)

## Key facts

- **NCT ID:** NCT03270956
- **Lead sponsor:** Prokidney
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-25
- **Primary completion:** 2022-11-17
- **Final completion:** 2022-11-17
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03270956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03270956, "A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03270956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*